United States · FDA National Drug Code directory
Sodium Polystyrene Sulfonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62135-340_06fcec70-ae79-a194-e063-6394a90a6ffa
- Product NDC
- 62135-340
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Sodium Polystyrene Sulfonate
- Labeler
- Chartwell RX, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160218
- Source listing expiry
- 20261231
Source-listed ingredients
- SODIUM POLYSTYRENE SULFONATE — 4.1 meq/g
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BOTTLE in 1 BOX (62135-340-11) / 15 g in 1 BOTTLE · 62135-340-11
- 453.6 g in 1 BOTTLE (62135-340-53) · 62135-340-53
- 15 g in 1 BOTTLE (62135-340-62) · 62135-340-62
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →